SynBioBeta Speaker
Una Ryan
Ulux
Founder and CEO
As CEO of several public , private and nonprofit companies, I have overseen many trials from phase 1 through approval. I am familiar with global national and orphan indications.
Sessions Featuring
Una
This Year
•
-
Human Health
Rewriting the Rules - Clinical Trial Reform in the Age of AI
AI-native drug discovery is accelerating molecule design, but clinical trials remain slow, expensive, and exclusionary. If we don’t modernize trial infrastructure, we create a bottleneck between computational breakthroughs and real-world patient impact. This breakout explores how to reform recruitment, eligibility, endpoints, biomarkers, and regulatory alignment to make U.S. trials more competitive and globally scalable.
Featuring
Mark Atalla
ONC
ONC Deputy, Policy
Andrea Bild
City of Hope
Professor & Director
Jacob Glanville
Centivax
CEO
Building a universal antivenom
Una Ryan
Ulux
Founder and CEO
Arman Sharma
HHS
Deputy CAIO
Zachary Gobst
Leapcure
CEO
Making clinical trials more equitable and accessible.
•
-
Human Health
Rewriting the Rules - Clinical Trial Reform in the Age of AI
AI-native drug discovery is accelerating molecule design, but clinical trials remain slow, expensive, and exclusionary. If we don’t modernize trial infrastructure, we create a bottleneck between computational breakthroughs and real-world patient impact. This breakout explores how to reform recruitment, eligibility, endpoints, biomarkers, and regulatory alignment to make U.S. trials more competitive and globally scalable.
Featuring
Mark Atalla
ONC
ONC Deputy, Policy
Andrea Bild
City of Hope
Professor & Director
Jacob Glanville
Centivax
CEO
Building a universal antivenom
Una Ryan
Ulux
Founder and CEO
Arman Sharma
HHS
Deputy CAIO
Zachary Gobst
Leapcure
CEO
Making clinical trials more equitable and accessible.
